---
figid: PMC3922162__1475-2891-13-12-2
figtitle: Dotted line, inhibit; solid line, activate
organisms:
- Glycine max
- Solanum tuberosum
- Malus domestica
- Olea europaea
- Arachis hypogaea
- Fragaria x ananassa
- Helianthus annuus
- Theobroma cacao
- Musa acuminata
- Carthamus tinctorius
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- unidentified
- Salmo salar
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3922162
filename: 1475-2891-13-12-2.jpg
figlink: /pmc/articles/PMC3922162/figure/F2/
number: F2
caption: Dotted line, inhibit; solid line, activate. EPA, eicosapentaenoic acid; DHA,
  docosahexaenoic acid; GPR120, G protein-coupled receptor 120; JNK, JUN NH2-terminal
  kinase; TLR-4, toll-like-receptor 4; NF-κB, nuclear factor kappa-β; PPARγ, peroxisome
  proliferator-activated receptor γ; AA, arachidonic acid; PGE2, prostaglandins E2.
  Anti-inflammatory mechanisms of EPA and DHA. EPA and DHA inhibit NF-κB and JNK through
  binding with GPR120. Incorporation of these n-3 PUFA disrupts the translocation
  of TLR-4 into lipid raft, thus inactivates NF-κB pathway. Besides, EPA and DHA interfere
  with the TLR-4 signaling pathway via the downregulation of NADPH oxidase production,
  which results in the inhibition of NF-κB pathway. These fatty acids also activate
  PPARγ and, result in the upregulation of adiponectin and leptin secretion. In addition,
  the intake of EPA and DHA leads to antagonism of n-6 fatty acid arachidonic acid
  (AA).
papertitle: 'Modulation of obesity-induced inflammation by dietary fats: mechanisms
  and clinical evidence.'
reftext: Kim-Tiu Teng, et al. Nutr J. 2014;13:12-12.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9222281
figid_alias: PMC3922162__F2
figtype: Figure
redirect_from: /figures/PMC3922162__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3922162__1475-2891-13-12-2.html
  '@type': Dataset
  description: Dotted line, inhibit; solid line, activate. EPA, eicosapentaenoic acid;
    DHA, docosahexaenoic acid; GPR120, G protein-coupled receptor 120; JNK, JUN NH2-terminal
    kinase; TLR-4, toll-like-receptor 4; NF-κB, nuclear factor kappa-β; PPARγ, peroxisome
    proliferator-activated receptor γ; AA, arachidonic acid; PGE2, prostaglandins
    E2. Anti-inflammatory mechanisms of EPA and DHA. EPA and DHA inhibit NF-κB and
    JNK through binding with GPR120. Incorporation of these n-3 PUFA disrupts the
    translocation of TLR-4 into lipid raft, thus inactivates NF-κB pathway. Besides,
    EPA and DHA interfere with the TLR-4 signaling pathway via the downregulation
    of NADPH oxidase production, which results in the inhibition of NF-κB pathway.
    These fatty acids also activate PPARγ and, result in the upregulation of adiponectin
    and leptin secretion. In addition, the intake of EPA and DHA leads to antagonism
    of n-6 fatty acid arachidonic acid (AA).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Timp1
  - Decr1
  - H2-Aa
  - Ffar4
  - Tlr4
  - Mapk8
  - Nfkb1
  - TIMP1
  - DECR1
  - FFAR4
  - TLR4
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKB1
  - Pka-R2
  - aa
  - Toll-4
  - bsk
  - Dif
  - dl
  - Rel
  - PGE
---
